ZAVESCA caps 100 mg 84 pce

7680568980018 Pharmacode 2900363 CH-56898 A16AX06 07.99.0.

Active substances:

ZAVESCA caps 100 mg 84 pce
ZAVESCA caps 100 mg 84 pce
1 / 2
google

Details

GTIN
7680568980018
Pharmacode
2900363
Product number
5689801
CPT
-
Packaging group
84
Unit
Kapsel(n)
Composition
miglustatum 100 mg, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: E 172 (nigrum), lacca, pro capsula corresp. natrium 190 µg.

Articles (1)

Zavesca, Kapseln
Kapseln
84
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/10/2026
Patient information leaflet
Français
09/10/2026
Patient information leaflet
Italien
09/10/2026
Professional SmPC
Allemand
09/10/2026
Professional SmPC
Français
09/10/2026
Professional SmPC
Italien
09/10/2026

Detailed composition

Substance Quantity Type Category
miglustatum
100.0 MG Substance Wirkstoff (Principe actif)
carboxymethylamylum natricum A
- Substance HNIDK
povidonum K 30
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (nigrum)
- Substance FTODK
lacca
- Substance HNIDK
natrium
190.0 UG Substance HBESI

Reimbursement information

Public price
CHF 4883.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2005

Authorization holder

Advanz Pharma Specialty Medicine

8048 Zürich

Authorization information

Swissmedic authorization number
56898
Drug name
Zavesca, Kapseln
Galenic form
KAPS
ATC Code
A16AX06
Authorization status
Z
Dispensation category
B
First authorization
22/10/2004
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Behandlung des Morbus Gaucher Typ 1, Behandlung progressiver neurologischer Manifestationen bei erwachsenen und pädiatrischen Patienten mit Niemann-Pick-Krankheit Typ C

Packaging details

Description (FR)
ZAVESCA caps 100 mg 84 pce
Description (DE)
ZAVESCA Kaps 100 mg 84 Stk
Market launch
22/10/2004
Narcotic (BTM)
No

Available generics

Miglustat Dipharma, capsula rigida
CHF 4422.00
View
Buy us a coffee Explore the data